Published in Muscle Nerve on March 31, 2015
Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol (2005) 4.47
Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg (1989) 3.75
An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol (1982) 2.75
Acute compartment syndrome in tibial diaphyseal fractures. J Bone Joint Surg Br (1996) 2.34
Compartmental syndrome. An unified concept. Clin Orthop Relat Res (1976) 2.30
Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol (2006) 2.28
Lower limb compartment syndrome: course after delayed fasciotomy. J Trauma (1996) 1.95
Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc (1995) 1.88
Ischaemia complicating injury. A report of thirty-seven cases. J Bone Joint Surg Br (1968) 1.44
Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm (2013) 1.40
Relation between myofibers and connective tissue during muscle injury repair. Scand J Med Sci Sports (2000) 1.22
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol (2005) 1.16
Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J Appl Physiol (1985) (2006) 1.09
Determination of the compartment pressure threshold of muscle ischemia in a canine model. J Trauma (1994) 1.08
Activation of myogenic precursor cells after muscle injury. Med Sci Sports Exerc (1992) 1.08
Crush syndrome due to limb compression. Arch Surg (1987) 1.06
Quantitative aspects of normal locomotion in rats. Life Sci (1979) 1.06
Compartment syndromes and reperfusion injury. Surg Clin North Am (1988) 1.02
Hemodynamic changes in rat leg muscles during tourniquet-induced ischemia-reperfusion injury observed by near-infrared spectroscopy. Physiol Meas (2009) 1.02
Tourniquet-induced limb ischemia: a neurophysiologic animal model. Anesthesiology (1990) 0.94
Pathophysiology and mechanisms of compartment syndrome. Orthop Rev (1993) 0.92
Poloxamer-188 reduces muscular edema after tourniquet-induced ischemia-reperfusion injury in rats. J Trauma (2011) 0.90
Compression-induced muscle injury in rats that mimics compartment syndrome in humans. Am J Pathol (2011) 0.89
Capillarity, fibre types and fibre morphometry in different sampling sites across and along the tibialis anterior muscle of the rat. Cells Tissues Organs (2000) 0.87
Ischemic preconditioning prevents skeletal muscle tissue injury, but not nerve lesion upon tourniquet-induced ischemia. J Trauma (2007) 0.86
An animal model for the study of neuromuscular injury induced beneath and distal to a pneumatic tourniquet. J Orthop Res (1990) 0.82
Use of tissue ultrafiltration for treatment of compartment syndrome: a pilot study using porcine hindlimbs. J Orthop Trauma (2005) 0.81
Nerve function and structure beneath and distal to a pneumatic tourniquet applied to rabbit hindlimbs. Scand J Plast Reconstr Surg Hand Surg (1991) 0.81
Long-term myoneural function after an induced compartment syndrome in the canine hindlimb. Clin Orthop Relat Res (1985) 0.81
Muscle cells become necrotic rather than apoptotic during reperfusion of ischaemic skeletal muscle. Int J Exp Pathol (1999) 0.79
Characterization of fiber types in different muscles of the hindlimb in female weanling and adult Wistar rats. Acta Histochem Cytochem (2011) 0.79
The effect of a hypobaric, hypoxic environment on acute skeletal muscle edema after ischemia-reperfusion injury in rats. J Surg Res (2009) 0.78
Compartment syndrome-induced microvascular dysfunction: an experimental rodent model. Can J Surg (2011) 0.77
Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpoints. J Pharmacol Toxicol Methods (2013) 0.77
Pathology study of rabbit calf muscles after repeated compression. J Orthop Sci (1998) 0.77
Ischaemia of peripheral nerve and muscle. J Clin Pathol Suppl (R Coll Pathol) (1977) 0.77
Threshold model for extremity compartment syndrome in swine. J Surg Res (2011) 0.76
Extremity compartment syndrome in pigs during hypobaric simulation of aeromedical evacuation. Aviat Space Environ Med (2011) 0.76
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol (2002) 4.61
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol (2004) 2.78
Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest (2002) 2.59
Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol (2007) 2.41
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc (2008) 2.26
A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol (2007) 2.26
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone (2005) 2.26
IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med (2010) 2.15
Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum (2006) 2.08
A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol (2007) 2.01
Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J Biol Chem (2007) 1.96
VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res (2005) 1.96
NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest (2012) 1.91
Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol (2008) 1.85
Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle. Am J Sports Med (2008) 1.83
Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A (2010) 1.79
Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol (2002) 1.74
Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve (2003) 1.61
Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther (2005) 1.59
Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev (2009) 1.51
Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials (2007) 1.48
Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol (2008) 1.42
Human pericytes for ischemic heart repair. Stem Cells (2013) 1.39
Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol (2003) 1.38
Enhancement of tendon-bone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer: a histological and biomechanical study. J Bone Joint Surg Am (2002) 1.38
Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun (2012) 1.37
Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations. Stem Cells (2007) 1.37
Tissue engineering and developmental biology: going biomimetic. Tissue Eng (2006) 1.34
The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med (2005) 1.33
Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tissue Eng (2006) 1.32
Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum (2009) 1.31
The impact of arterial hypertension on polytrauma and traumatic brain injury. Dtsch Arztebl Int (2012) 1.29
Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol (2008) 1.28
Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol (1985) (2003) 1.28
Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther (2009) 1.25
Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J Bone Miner Res (2005) 1.25
Pericyte-based human tissue engineered vascular grafts. Biomaterials (2010) 1.25
Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology (2003) 1.21
The vascular wall as a source of stem cells. Ann N Y Acad Sci (2005) 1.20
Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell (2008) 1.19
BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther (2002) 1.19
The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci (2002) 1.19
Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials (2007) 1.18
Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res (2006) 1.18
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am (2004) 1.16
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol (2005) 1.16
Gamma interferon as an antifibrosis agent in skeletal muscle. J Orthop Res (2003) 1.15
In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A (2010) 1.14
Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J Cell Physiol (2008) 1.11
Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum Gene Ther (2002) 1.11
Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther (2014) 1.10
Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation. J Bone Miner Res (2005) 1.09
Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J Appl Physiol (1985) (2006) 1.09
Accelerated aging of intervertebral discs in a mouse model of progeria. J Orthop Res (2010) 1.08
The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle. Tissue Eng Part A (2010) 1.08
Placental perivascular cells for human muscle regeneration. Stem Cells Dev (2010) 1.08
Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol (2011) 1.07
The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A (2009) 1.07
Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater (2008) 1.07
Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am J Sports Med (2008) 1.07
Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol (2002) 1.07
Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect. Plast Reconstr Surg (2010) 1.06
Human blood-vessel-derived stem cells for tissue repair and regeneration. J Biomed Biotechnol (2012) 1.04
Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res (2007) 1.04
Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol (1985) (2007) 1.04
The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum (2008) 1.04
Muscle-derived stem cells for musculoskeletal tissue regeneration and repair. Transpl Immunol (2004) 1.04
Biologic approaches to enhance rotator cuff healing after injury. J Shoulder Elbow Surg (2012) 1.03
Use of an antifibrotic agent improves the effect of platelet-rich plasma on muscle healing after injury. J Bone Joint Surg Am (2013) 1.03
AAV-directed muscular dystrophy gene therapy. Expert Opin Biol Ther (2010) 1.03
Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity. Stem Cells (2015) 1.02
Biomechanical cadaver testing of a fixed-angle plate in comparison to tension wiring and screw fixation in transverse patella fractures. Injury (2012) 1.02
Isolation and characterization of human anterior cruciate ligament-derived vascular stem cells. Stem Cells Dev (2011) 1.02
Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci U S A (2011) 1.02
Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J Am Acad Orthop Surg (2008) 1.02
Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells. Sarcoma (2013) 1.02
Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther (2007) 1.02
Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum (2009) 0.99
Noninvasive monitoring and tracking of muscle stem cell transplants. Transplantation (2004) 0.99
Intramuscular transplantation of muscle-derived stem cells accelerates skeletal muscle healing after contusion injury via enhancement of angiogenesis. Am J Sports Med (2011) 0.99
Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology (2004) 0.99
Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells. Front Oncol (2013) 0.98
Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther (2010) 0.98
The effect of muscle loading on skeletal muscle regenerative potential: an update of current research findings relating to aging and neuromuscular pathology. Am J Phys Med Rehabil (2009) 0.98
The effect of relaxin treatment on skeletal muscle injuries. Am J Sports Med (2005) 0.97
Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther (2011) 0.97